Acute promyelocytic leukemia, microgranular variant

Slides:



Advertisements
Similar presentations
RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.
Advertisements

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Hairy Cell Leukemia Variant Has Similar Survival to Classical Disease Despite Poorer Responses to Initial Therapy: A 30-Year Experience from Memorial Sloan.
Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry by Po-Lin Chiu, George M. Bou-Assaf,
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? by Ching-Hon Pui, Charles G. Mullighan, William E. Evans, and Mary.
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients by Mikkael A. Sekeres, Paul Elson,
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Determination of acute lung injury after repeated platelet transfusions by Laurence Corash, Jin Sying Lin, Claire D. Sherman, and Joseph Eiden Blood Volume.
Uncontrolled Wnt signaling causes leukemia
Trails Carolina
Therapy Programs Provider: Trails Carolina
Trails Carolina: Social Media Profiles
Hydroxyurea makes inflammation “just right”?
EBV DNA: a Hodgkin lymphoma biomarker?
by Henrik Frederiksen, and Kai Schmidt
Neonatal GATA1 mutant clones under the radar
Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura
Defects in DBA: more than meets the eye
Next-generation leukemia immunotherapy
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic.
Retroviral and Chemical Mutagenesis Identifies Pax5 as a Tumor Suppressor in B-Progenitor Acute Lymphoblastic Leukemia by Jinjun Dang, Charles G Mullighan,
Gupta V, Tallman MS, Weisdorf DJ
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
by Zhenping Zhu Blood Volume 108(6): September 15, 2006
Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.
Rituximab-induced tumor cell agglutination
Tax fingerprint in adult T-cell leukemia
Transplants for the elderly in myeloma
Critiquing Cryos by Morie Gertz Blood Volume 111(11):
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia:
Autologous Transplantation Therapy for Chronic Myelogenous Leukemia
CMV: when bad viruses turn good
What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):
Deep mining of the RBC proteome
by Wolfram Springer, Alexander von Ruecker, and Roswitha Dickerhoff
by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T
An actuarial GPS for hemophilic longevity
Taking a leaf from the book of oral tolerance
by Sabah Sallah, and Jim Y. Wan
by Jayesh Mehta Blood Volume 112(2): July 15, 2008
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reaction identifies also patients with B-precursor.
Stage C or not stage C…? by Claire Dearden Blood
ROCK and Rho(ll) in bone marrow
CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not by Naoko Ishibe, Maher Albitar, Iman.
Latest lymphoma classification is skin deep
HU for acute treatment of sickle VOC?
The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score by Ollivier Legrand, Jean-Yves Perrot, Marion Baudard, Annie.
Final Report Of Single-Center Study Of Chemotherapy Plus Dasatinib For The Initial Treatment Of Patients With Philadelphia-Chromosome Positive Acute Lymphoblastic.
Patient-Reported Outcomes from a Global Phase 3 Randomized Controlled Trial of Inotuzumab Ozogamicin Versus Standard of Care Chemotherapy for Relapsed/Refractory.
Low Dose Thymoglobulin Results In Improved Outcomes After Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) For Patients With Acute Myeloid.
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
by Martin S. Tallman, Donna Neuberg, John M. Bennett, Christopher J
by John Anastasi, Rizwan Moinuddin, and Christopher Daugherty
Immunotherapy for acute lymphoblastic leukemia: from famine to feast
Christopher C. Dvorak, Rajni Agarwal, Gary V. Dahl, John J
Allogeneic Hematopoietic Stem Cell Transplantation in Adult Acute Lymphocytic Leukemia: Impact of Donor Source on Survival  Priya Kumar, Todd E. Defor,
Mohamed A. Kharfan-Dabaja, Yasser R. Abou Mourad, Hugo F
Overcoming “aspirin resistance” in MPN
Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged ≥65 Years with Acute Myeloid Leukemia by Andrew Wei, Stephen.
Treatment versus Transplant for Challenging Hematologic Disorders
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Mary Eapen  Biology of Blood and Marrow Transplantation 
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
In Memoriam: E. Donnall Thomas
by Lucy A. Godley, and Akiko Shimamura
Initial treatment of CLL: integrating biology and functional status
Health-Related Quality of Life (HRQoL) of Blinatumomab Versus Standard of Care (SOC) Chemotherapy in Patients with Relaspsed or Refractory Philadelphia.
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Cold agglutinin disease
Presentation transcript:

Acute promyelocytic leukemia, microgranular variant Blood Volume 104(3):605-605 August 1, 2004 ©2004 by American Society of Hematology

John J. Lazarchick, Department of Pathology, Mobile Infirmary, and John Lazarchick, Department of Pathology, Medical University of South Carolina. John J. Lazarchick, Department of Pathology, Mobile Infirmary, and John Lazarchick, Department of Pathology, Medical University of South Carolina American Society of Hematology Blood 2004;104:605 ©2004 by American Society of Hematology